Quarterly report [Sections 13 or 15(d)]

REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)

v3.26.1
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
3 Months Ended
Mar. 31, 2026
REVENUES FROM CONTRACTS WITH CUSTOMERS  
Schedule of disaggregation of net revenues

Three-Month Periods Ended March 31, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Emrosi®

$

6,252

$

2,070

Qbrexza®

5,028

5,161

Accutane®

 

3,314

 

3,655

Foam franchise products (Amzeeq® & Zilxi®)

1,050

1,526

Other / legacy

277

727

Total product revenues

$

15,921

$

13,139

Schedule of other revenue

Three-Month Periods Ended March 31, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Royalties on sales of Amzeeq by Cutia

$

40

$

Total other revenue

$

40

$